Quadrant Capital Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $411K | Buy |
|
|||||
|
2025
Q2 | $398K | Buy |
|
|||||
|
2025
Q1 | $270K | Buy |
|
|||||
|
2024
Q4 | $84.2K | Sell |
|
|||||
|
2024
Q3 | $91.6K | Sell |
|
|||||
|
2024
Q2 | $97.1K | Hold |
|
|||||
|
2024
Q1 | $127K | Sell |
|
|||||
|
2023
Q4 | $115K | Buy |
|
|||||
|
2023
Q3 | $73.9K | Sell |
|
|||||
|
2023
Q2 | $80.5K | Sell |
|
|||||
|
2023
Q1 | $86.8K | Sell |
|
|||||
|
2022
Q4 | $106K | Hold |
|
|||||
|
2022
Q3 | $96K | Sell |
|
|||||
|
2022
Q2 | $110K | Buy |
|
|||||
|
2022
Q1 | $120K | Sell |
|
|||||
|
2021
Q4 | $182K | Sell |
|
|||||
|
2021
Q3 | $207K | Buy |
|
|||||
|
2021
Q2 | $176K | Buy |
|
|||||
|
2021
Q1 | $134K | Buy |
|
|||||
|
2020
Q4 | $97K | Sell |
|
|||||
|
2020
Q3 | $92K | Hold |
|
|||||
|
2020
Q2 | $71K | Sell |
|
|||||
|
2020
Q1 | $77K | Buy |
|
|||||
|
2019
Q4 | $55K | Hold |
|
|||||
|
2019
Q3 | $50K | Hold |
|
|||||
|
2019
Q2 | $52K | Sell |
|
|||||
|
2019
Q1 | $100K | Buy |
|
|||||
|
2018
Q4 | $41K | Hold |
|
|||||
|
2018
Q3 | $50K | Buy |
|
|||||
|
2018
Q2 | $29K | Hold |
|
|||||
|
2018
Q1 | $27K | Hold |
|
|||||
|
2017
Q4 | $27K | Hold |
|
|||||
|
2017
Q3 | $27K | Buy |
|
|||||
|
2017
Q2 | $14K | Hold |
|
|||||
|
2017
Q1 | $16K | Buy |
|
|||||
|
2016
Q4 | $9K | Hold |
|
|||||
|
2016
Q3 | $10K | Hold |
|
|||||
|
2016
Q2 | $10K | Buy |
|
|||||
|
2016
Q1 | $8K | Buy |
|
|||||
|
2015
Q4 | $1K | Hold |
|
|||||
|
2015
Q3 | $1K | Hold |
|
|||||
|
2015
Q2 | $1K | Buy |
|